- Exchange: ASE
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Snapshot for Pharmaxis Ltd (PXS)
| Open: | 0.2450 | Day's Range: | 0.1700 - 0.2550 | Volume: | 21,148,744 |
|---|---|---|---|---|---|
| Previous Close: | 0.1700 | 52wk Range: | 0.1225 - 1.4200 | 1-Yr Rtn: | -84.19% |
Key Statistics for PXS
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(06/2013) | - |
| Relative P/E vs. AS51 | - |
| Earnings Per Share (AUD) (ttm) | -0.1320 |
| Est. EPS (AUD) (06/2013) | -0.1290 |
| Est. PEG Ratio | - |
| Market Cap (M AUD) | 52.45 |
| Shares Outstanding (M) | 308.54 |
| 30 Day Average Volume | 4,397,951 |
| Price/Book (mrq) | 0.5819 |
| Price/Sale (ttm) | 19.7623 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/17/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PXS
Company Profile & Key Executives for PXS
Pharmaxis Ltd. is a pharmaceutical company which develops therapeutic products for the human chronic respiratory and autoimmune diseases. The Company operates in Australia.
| Gary Jonathan PhillipsChief Executive Officer | David Morris McGarveyCFO/Secretary |
| Ian Alexander McDonaldChief Scientific Officer | Howard George FoxChief Medical Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PXS News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page